Boston, Massachusetts, United States The main department of described VC is located in the Boston. The venture was found in North America in United States.
The higher amount of exits for fund were in 2012. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2013. The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this Mass Medical Angels performs on 21 percentage points less the average number of lead investments.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Mass Medical Angels, startups are often financed by Cherrystone Angel Group, Maine Angels, Oleg Uritsky. The meaningful sponsors for the fund in investment in the same round are LaunchPad Venture Group, Boston Harbor Angels, Beacon Angels. In the next rounds fund is usually obtained by Maine Angels, Cherrystone Angel Group, Beta Fund.
This organization was formed by Carl Berke, Pushwaz Virk, Richard Anders, Roger Kitterman. We also calculated 7 valuable employees in our database.
The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Personal Health, Clinical Trials. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Daktari Diagnostics, InfoBionic, Capillary Biomedical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Related Funds
Funds with similar focus
| Fund Name | Location |
| BlueBox Ventures | Mexico, Michoacán, Morelia |
| Chugai Pharmaceutical | Chiyoda, Japan |
| Coventry Capital | Delaware, United States, Wilmington |
| Cycle Ventures | - |
| Endurance Companies | California, San Francisco, United States |
| Fluor Corporation | Irving, Texas, United States |
| Folens | - |
| Henley Business Angels | Berkshire, New York, United States |
| Ingenious Media | England, London, United Kingdom |
| Lantronix | California, Irvine, United States |
| Moneysupermarket Group | Cheshire, Chester, United Kingdom |
| Pacific Venture Capital | - |
| Sprout Fund LP | Alberta, Canada, Edmonton |
| Themis Computer | California, Fremont, United States |
| Tortola Capital | - |
| Tosa shimizu | Japan, Kanagawa Prefecture, Miura |
| Up Capital | Canada, Ontario, Toronto |
| Zhongji Guquan Touzi | China, Guangdong, Zhuhai |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Astrocyte Pharmaceuticals | $6M | 18 Aug 2023 | Cambridge, Massachusetts, United States | ||
Astrocyte Pharmaceuticals | $6M | 03 May 2021 | Cambridge, Massachusetts, United States | ||
Coviu | $6M | 07 Dec 2020 | Brisbane City, Queensland, Australia | ||
Capillary Biomedical | $2M | 14 Aug 2018 | Irvine, California, United States | ||
Astrocyte Pharmaceuticals | $2M | 17 Jul 2017 | Cambridge, Massachusetts, United States | ||
Sentien Biotechnologies | $12M | 04 Apr 2017 | Massachusetts, United States | ||
InfoBionic | $17M | 08 Apr 2014 | Massachusetts, United States | ||
Sentieon | $3M | 04 Apr 2014 | Mountain View, California, United States | ||
Siamab Therapeutics | $1M | 05 Feb 2014 | Newton, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Astrocyte Pharmaceuticals | $6M | 18 Aug 2023 | Cambridge, Massachusetts, United States | ||
Astrocyte Pharmaceuticals | $6M | 03 May 2021 | Cambridge, Massachusetts, United States | ||
Coviu | $6M | 07 Dec 2020 | Brisbane City, Queensland, Australia | ||
Capillary Biomedical | $2M | 14 Aug 2018 | Irvine, California, United States | ||
Astrocyte Pharmaceuticals | $2M | 17 Jul 2017 | Cambridge, Massachusetts, United States | ||
Sentien Biotechnologies | $12M | 04 Apr 2017 | Massachusetts, United States | ||
InfoBionic | $17M | 08 Apr 2014 | Massachusetts, United States | ||
Sentieon | $3M | 04 Apr 2014 | Mountain View, California, United States | ||
Siamab Therapeutics | $1M | 05 Feb 2014 | Newton, Massachusetts, United States |
